You haven't searched anything yet.
AboutCivica
Civicais a 501(c)(4) social welfare organization established in 2018 by healthsystems and philanthropies to reduce chronic generic drug shortages and relatedhigh prices in the United States. Civica is led by an experienced team ofhealthcare and pharmaceutical industry leaders.
Today,more than 55 health systems have joined Civica. They represent over 1,500hospitals and one-third of all U.S. hospital beds. Civica has also begun tosupply the U.S. Department of Veteran’s Affairs, the U.S. Department of Defenseand the U.S. Strategic National Stockpile of essential medicines.
Civicarecently announced plans to expand its mission, via a unit called CivicaScript,to into the outpatient pharmacy space and to manufacture and distributeinsulins that, once approved, will be available to people with diabetes atsignificantly lower prices than insulins currently on the market. Theavailability of Civica’s affordable insulins, beginning in 2024, will benefitpeople with diabetes who have been forced to choose between life sustainingmedicines and living expenses, particularly those uninsured or underinsured whooften pay the most out of pocket for their medications.
Civica’smission is to ensure that quality generic medications are accessible andaffordable to everyone. Since established, the #1 Policy for the Civica teamhas been “Do What Is in the Best Interest of Patients.” Civica’smanufacturing facility in Petersburg, Virginia, is the future home ofaffordable insulin and essential sterile injectable medicines. The facility iscurrently in late-stage construction and hiring for the site is well-underway.
To findout more about how Civica’s innovative model is directly impacting patientcare, click here to read a summary from the NewEngland Journal of Medicine. (https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0189)
To learnmore about Civica’s plans to bring affordable insulin to Americans living withdiabetes, click here to read an article in BioSpace.
(https://www.biospace.com/article/civica-is-rallying-leaders-to-make-insulin-affordable-by-2024-/)
Job Description
The Manufacturing Specialist II will play a key part in the facility start up with primary responsibilities focused around supporting daily manufacturing operations on the cartridge line and the timely production of pharmaceuticals at the Civica Petersburg, VA site. In collaboration with stakeholders, this position will support cross-functional teams with manufacturing production execution, running equipment, new product introductions, tech transfer, equipment qualifications, change management, investigations, training, and development. The ideal candidate will have a consistent track record of achieving results in a face-paced manufacturing environment.
Essential Duties and Responsibilities:
Basic Qualifications and Capabilities:
Preferred Qualifications:
Full Time
$41k-55k (estimate)
04/11/2024
05/21/2024
civicarx.org
Lehi, UT
<25